Decoy Therapeutics Inc. (DCOY) vs Genprex, Inc. (GNPX)
A side-by-side comparison of Decoy Therapeutics Inc. and Genprex, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DCOY
Decoy Therapeutics Inc.
$1.55HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
GNPX
Genprex, Inc.
$2.61HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — DCOY vs GNPX
growth of $100 · dividends reinvested · last 9yDCOY -100.0% (-81.4%/yr)GNPX -100.0% (-71.3%/yr)GNPX compounded faster over this window
Log scale — wide-divergence pair
DCOY GNPX
DCOY vs GNPX: by the numbers
- •GNPX is the larger company ($1M vs $824550 market cap).
Metrics side by side
Valuation
| Metric | DCOY | GNPX |
|---|---|---|
| P/B ratio | 0.19 | 0.09 |
Profitability
| Metric | DCOY | GNPX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -334.41% | -111.51% |
| ROIC | -343.55% | -107.08% |
Growth (annualized)
| Metric | DCOY | GNPX |
|---|---|---|
| Total return CAGR (5Y) | -86.39% | -88.16% |
Frequently asked
- How have DCOY and GNPX total returns compared?
- Over the past 5 years, DCOY delivered -86.39% and GNPX delivered -88.16% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.